Vasodilatory Effect of the Stable Vasoactive Intestinal Peptide Analog RO 25-1553 in Murine and Rat Lungs

RATIONALE: Stable analogs of vasoactive intestinal peptide (VIP) have been proposed as novel line of therapy in chronic obstructive pulmonary disease (COPD) based on their bronchodilatory and anti-inflammatory effects. We speculated that VIP analogs may provide additional benefits in that they exert...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Jun, Wang, Liming, Yin, Ning, Tabuchi, Arata, Kuppe, Hermann, Wolff, Gerhard, Kuebler, Wolfgang M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777882/
https://www.ncbi.nlm.nih.gov/pubmed/24069452
http://dx.doi.org/10.1371/journal.pone.0075861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777882/
https://www.ncbi.nlm.nih.gov/pubmed/24069452
http://dx.doi.org/10.1371/journal.pone.0075861

Ejemplares similares